Shelley George
- Hepatology top 0.2%
- Epidemiology top 1%
- Infectious Diseases top 5%
- Rheumatology top 5%
- Molecular Biology
- Co-authors
- Robert S. KauffmanNathalie AddaNezam H. AfdhalHendrik W. ReesinkTara L. KiefferGeoffrey DusheikoLeif BengtssonJean–Michel Pawlotsky
- Topics
- Hepatitis C virus research (23 papers)HIV/AIDS drug development and treatment (11 papers)Hepatitis B Virus Studies (10 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Shelley George
30 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Hepatology 2.0k
- Epidemiology 1.7k
- Infectious Diseases 510
- Rheumatology 232
- Molecular Biology 103
Countries citing papers authored by Shelley George
This map shows the geographic impact of Shelley George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley George more than expected).
Fields of papers citing papers by Shelley George
This network shows the impact of papers produced by Shelley George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley George. The network helps show where Shelley George may publish in the future.
Co-authorship network of co-authors of Shelley George
This figure shows the co-authorship network connecting the top 25 collaborators of Shelley George. A scholar is included among the top collaborators of Shelley George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelley George. Shelley George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination with Sofosbuvir in Naive Subjects with HCV Genotype 1 Short Title: Telaprevir & Sofosbuvir in HCV Genotype 1 | 2 |
| 3 | 1 | |
| 4 | 29 | |
| 5 | 8 | |
| 6 | 12 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infectionbreakdown → | 566 |
| 10 | 39 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 2 | |
| 14 | 6 | |
| 15 | 10 | |
| 16 | 8 | |
| 17 | 0 | |
| 18 | 1 | |
| 19 | Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infectionbreakdown → | 771 |
| 20 | 9 |
About Shelley George
Shelley George is a scholar working on Hepatology, Rheumatology and Infectious Diseases, having authored 32 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), HIV/AIDS drug development and treatment (11 papers) and Hepatitis B Virus Studies (10 papers). The work is most often cited by research in Hepatology (2.0k citations), Epidemiology (1.7k citations) and Infectious Diseases (510 citations). Shelley George has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Robert S. Kauffman, Nathalie Adda, Nezam H. Afdhal, Hendrik W. Reesink, Tara L. Kieffer, Geoffrey Dusheiko, Leif Bengtsson, Jean–Michel Pawlotsky, Stefan Zeuzem and Stanislas Pol. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.